Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
20,000
-4,000
-17% -$365K 0.1% 109
2026
Q1
$2.46M Sell
24,000
-3,600
-13% -$406K 0.17% 77
2025
Q4
$3.46M Sell
27,600
-2,500
-8% -$318K 0.22% 69
2025
Q3
$4.03M Hold
30,100
0.26% 59
2025
Q2
$4.09M Hold
30,100
0.3% 60
2025
Q1
$3.99M Hold
30,100
0.33% 57
2024
Q4
$3.4M Buy
+30,100
New +$3.48M 0.27% 55

Other funds holding ABT

Triglav Skladi's ABT Position: Q2 2026 in Review

Triglav Skladi reduced its Abbott (ABT) stake by 17% in Q2 2026, selling an estimated $365K and leaving 20,000 shares worth $1.81M. The position accounts for 0.1% of the portfolio, ranked #109.

Triglav Skladi first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.09M in Q2 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Triglav Skladi held 20,000 shares of Abbott worth $1.81M as of Q2 2026.
  • Triglav Skladi sold 4,000 Abbott shares in Q2 2026, an estimated $365K.
  • Abbott made up 0.1% of Triglav Skladi's portfolio in Q2 2026, its #109 holding.
  • Triglav Skladi first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Abbott position peaked at $4.09M in Q2 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.